Once weekly administration of etanercept 50mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension
BackgroundIn previous studies, etanercept 25mg twice weekly (BIW) or 50mg BIW significantly reduced disease severity in patients with plaque psoriasis and demonstrated a favourable safety profile. ObjectivesTo assess the efficacy and safety of etanercept 50mg administered once weekly (QW) compared w...
Gespeichert in:
Veröffentlicht in: | British journal of dermatology (1951) 2008-11, Vol.159 (5), p.1177-1185 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!